Oncology and Hematology - Global Oncology Academy

Episodes 129-144 of 296

What Is the Current Standard for First-Line Treatment of Metastatic HER2-Negative G/GEJ Cancers?
What Is the Current Standard for First-Line Treatment of Metastatic HER2-Negative G/GEJ Cancers?
MinuteCE®
What Is the Current Standard for First-Line Treatment of Metastatic HER2-Negative G/GEJ Cancers?
1.25 program credits
- Yelena Janjigian, MD
1.25 program credits
MinuteCE®
Navigating Challenges in Metastatic Gastric/GEJ Cancer Management: Advancements in Biomarker-Directed Therapies
1.25 credits 11 episodes
- Yelena Janjigian, MD
- Samuel J. Klempner, MD
1.25 credits 11 episodes
What Is the Current Standard for First-Line Treatment of Metastatic HER2-Positive G/GEJ Cancers?
What Is the Current Standard for First-Line Treatment of Metastatic HER2-Positive G/GEJ Cancers?
MinuteCE®
What Is the Current Standard for First-Line Treatment of Metastatic HER2-Positive G/GEJ Cancers?
1.25 program credits
- Yelena Janjigian, MD
1.25 program credits
HER2 & PD-L1: Exploring Clinical Characteristics of G/GEJ Cancers in Relation to Biomarker Positivity
HER2 & PD-L1: Exploring Clinical Characteristics of G/GEJ Cancers in Relation to Biomarker Positivity
MinuteCE®
HER2 & PD-L1: Exploring Clinical Characteristics of G/GEJ Cancers in Relation to Biomarker Positivity
1.25 program credits
- Yelena Janjigian, MD
1.25 program credits
The Necessity of a Multidisciplinary Approach Through the mCRPC Treatment Journey
The Necessity of a Multidisciplinary Approach Through the mCRPC Treatment Journey
Project Oncology®
The Necessity of a Multidisciplinary Approach Through the mCRPC Treatment Journey
- Jessica E. Hawley M.D. M.S.
Prostate Cancer Care: Overcoming Challenges in Delivering Germline Testing to Veterans
Prostate Cancer Care: Overcoming Challenges in Delivering Germline Testing to Veterans
Project Oncology®
Prostate Cancer Care: Overcoming Challenges in Delivering Germline Testing to Veterans
- Daniel Kwon, MD
ASCO GU 2024: Reviewing Updated Practice Guidelines for Prostate Cancer
ASCO GU 2024: Reviewing Updated Practice Guidelines for Prostate Cancer
Project Oncology®
ASCO GU 2024: Reviewing Updated Practice Guidelines for Prostate Cancer
- Jessica E. Hawley M.D. M.S.
Treating High-Risk Biochemically Recurrent Prostate Cancer: An Update from ASCO-GU
Treating High-Risk Biochemically Recurrent Prostate Cancer: An Update from ASCO-GU
Project Oncology®
Treating High-Risk Biochemically Recurrent Prostate Cancer: An Update from ASCO-GU
- Neal Shore, MD
Key Tests That Play a Crucial Role in Accurately Diagnosing GU Cancers
Key Tests That Play a Crucial Role in Accurately Diagnosing GU Cancers
Project Oncology®
Key Tests That Play a Crucial Role in Accurately Diagnosing GU Cancers
Addressing Health Equity in Genitourinary Cancer Clinical Trials
Addressing Health Equity in Genitourinary Cancer Clinical Trials
Project Oncology®
Addressing Health Equity in Genitourinary Cancer Clinical Trials
Maximizing Benefit with the Expanding Options for Gastric Cancer: Patient Selection and Management
Maximizing Benefit with the Expanding Options for Gastric Cancer: Patient Selection and Management
CME/CE
Maximizing Benefit with the Expanding Options for Gastric Cancer: Patient Selection and Management
1.00 credit
- James M. Cleary, MD, PhD
- Kathleen Madden, FNP, MSN, AOCNP, APHN
1.00 credit
An Exploration of Current and Emerging Therapies for mCRPC
An Exploration of Current and Emerging Therapies for mCRPC
Project Oncology®
An Exploration of Current and Emerging Therapies for mCRPC
How Modulation of Apoptotic Pathways Can Fill Important Unmet Needs in LA SCCHN
How Modulation of Apoptotic Pathways Can Fill Important Unmet Needs in LA SCCHN
CME/CE
How Modulation of Apoptotic Pathways Can Fill Important Unmet Needs in LA SCCHN
0.25 credits
- Jonathan D. Schoenfeld, MD, MPhil, MPH
- Robert L. Ferris, MD, PhD
0.25 credits
Accelerating Evidence-Based Care in LA SCCHN
Accelerating Evidence-Based Care in LA SCCHN
CME/CE
Accelerating Evidence-Based Care in LA SCCHN
0.25 credits
- Ezra Cohen, MD, FRCPSC, FASCO
- Sue S. Yom, MD, PhD
0.25 credits
SABCS 2023: A Look into New Research for Inflammatory Breast Cancer
SABCS 2023: A Look into New Research for Inflammatory Breast Cancer
Project Oncology®
SABCS 2023: A Look into New Research for Inflammatory Breast Cancer
- Filipa Lynce, MD
Inflammatory Breast Cancer: A New Scoring System Proposed
Inflammatory Breast Cancer: A New Scoring System Proposed
Project Oncology®
Inflammatory Breast Cancer: A New Scoring System Proposed
- Filipa Lynce, MD

Previous
1
2
…
7
8
9
10
11
…
18
19
Next

9/11